Airborne SARS CoV-2 detection allows for adaptive mitigation of virus - Case Stduy

The University of Maryland, Baltimore County uses Smiths Detection’s Bioflash Biological Identifier to help confirm presence of virus in the air allowing for real time response to covid-19.

Stop the Spread of Covid-19
At the start of the COVID-19 pandemic, Smiths Detection’s team based at its Biotechnology Center of Excellence in Baltimore, MD, began developing a new capability to detect airborne SARS-CoV-2 with its BioFlash Biological identifier.

The instrument collects and analyses air samples using sensitive, selective and rapid detection technology to identify the presence of dangerous pathogens onsite without the need to involve a laboratory. The development team at Smiths Detection created a new consumable to be used in the BioFlash to target the SARS-CoV-2 virus from an aerosol sample. Following successful internal testing, Smiths Detection has been engaged in various external studies to further verify the COVID-19 detection capability, including working with the USAMRIID, who verified that the BioFlash could identify the aerosolized virus in a laboratory setting.